KA
Abouir, Kenza
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| The Impact of Dexamethasone and Prednisone on Apixaban and Rivaroxaban Exposure in COVID-19 Patients : A Physiologically Based Pharmacokinetic Modeling Study | Clinical pharmacology & therapeutics |  | 2025 | 64 | 204 | ||
| Assessing the intrinsic and extrinsic factors of pharmacokinetic variability for precision medicine: A focus on CYP2C19 and the influence of genetic polymorphisms on drug interactions |  | 2024 | 287 | 9 | |||
| Stereoselective separation of omeprazole and 5-hydroxy-omeprazole using dried plasma spots and a heart-cutting 2D-LC approach for accurate CYP2C19 phenotyping | Journal of chromatography. B | | 2024 | 103 | 115 | ||
| Dexamethasone and Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia | JAMA | | 2022 | 170 | 0 | ||
| Dexamethasone exposure in normal-weight and obese hospitalized COVID-19 patients: An observational exploratory trial | Clinical and translational science | | 2022 | 152 | 123 | ||
| Reviewing Data Integrated for PBPK Model Development to Predict Metabolic Drug-Drug Interactions: Shifting Perspectives and Emerging Trends | Frontiers in pharmacology | | 2021 | 183 | 247 |
